159 related articles for article (PubMed ID: 32436951)
1. Excess Morbidity Persists in Patients With Cushing's Disease During Long-term Remission: A Swedish Nationwide Study.
Papakokkinou E; Olsson DS; Chantzichristos D; Dahlqvist P; Segerstedt E; Olsson T; Petersson M; Berinder K; Bensing S; Höybye C; Edén-Engström B; Burman P; Bonelli L; Follin C; Petranek D; Erfurth EM; Wahlberg J; Ekman B; Åkerman AK; Schwarcz E; Bryngelsson IL; Johannsson G; Ragnarsson O
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32436951
[TBL] [Abstract][Full Text] [Related]
2. Psychotropic Drugs in Patients with Cushing's Disease Before Diagnosis and at Long-Term Follow-Up: A Nationwide Study.
Bengtsson D; Ragnarsson O; Berinder K; Dahlqvist P; Edén Engström B; Ekman B; Höybye C; Burman P; Wahlberg J
J Clin Endocrinol Metab; 2021 May; 106(6):1750-1760. PubMed ID: 33567076
[TBL] [Abstract][Full Text] [Related]
3. Predictors of mortality and long-term outcomes in treated Cushing's disease: a study of 346 patients.
Lambert JK; Goldberg L; Fayngold S; Kostadinov J; Post KD; Geer EB
J Clin Endocrinol Metab; 2013 Mar; 98(3):1022-30. PubMed ID: 23393167
[TBL] [Abstract][Full Text] [Related]
4. Surviving ectopic Cushing's syndrome: quality of life, cardiovascular and metabolic outcomes in comparison to Cushing's disease during long-term follow-up.
Osswald A; Deutschbein T; Berr CM; Plomer E; Mickisch A; Ritzel K; Schopohl J; Beuschlein F; Fassnacht M; Hahner S; Reincke M
Eur J Endocrinol; 2018 Aug; 179(2):109-116. PubMed ID: 29875286
[TBL] [Abstract][Full Text] [Related]
5. The incidence of Cushing's disease: a nationwide Swedish study.
Ragnarsson O; Olsson DS; Chantzichristos D; Papakokkinou E; Dahlqvist P; Segerstedt E; Olsson T; Petersson M; Berinder K; Bensing S; Höybye C; Edén Engström B; Burman P; Bonelli L; Follin C; Petranek D; Erfurth EM; Wahlberg J; Ekman B; Åkerman AK; Schwarcz E; Bryngelsson IL; Johannsson G
Pituitary; 2019 Apr; 22(2):179-186. PubMed ID: 30799512
[TBL] [Abstract][Full Text] [Related]
6. Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature.
Clayton RN; Raskauskiene D; Reulen RC; Jones PW
J Clin Endocrinol Metab; 2011 Mar; 96(3):632-42. PubMed ID: 21193542
[TBL] [Abstract][Full Text] [Related]
7. Comorbidities in patients with non-functioning pituitary adenoma: influence of long-term growth hormone replacement.
Hammarstrand C; Ragnarsson O; Bengtsson O; Bryngelsson IL; Johannsson G; Olsson DS
Eur J Endocrinol; 2018 Oct; 179(4):229-237. PubMed ID: 30299891
[TBL] [Abstract][Full Text] [Related]
8. Effect of primary empty sella syndrome on pituitary surgery for Cushing's disease.
Mehta GU; Bakhtian KD; Oldfield EH
J Neurosurg; 2014 Sep; 121(3):518-26. PubMed ID: 24857241
[TBL] [Abstract][Full Text] [Related]
9. [Predictors of long-term remission after transsphenoidal surgery in Cushing's disease].
Abellán Galiana P; Fajardo Montañana C; Riesgo Suárez PA; Gómez Vela J; Escrivá CM; Lillo VR
Endocrinol Nutr; 2013 Oct; 60(8):475-82. PubMed ID: 23266144
[TBL] [Abstract][Full Text] [Related]
10. Outcome of Cushing's disease following transsphenoidal surgery in a single center over 20 years.
Hassan-Smith ZK; Sherlock M; Reulen RC; Arlt W; Ayuk J; Toogood AA; Cooper MS; Johnson AP; Stewart PM
J Clin Endocrinol Metab; 2012 Apr; 97(4):1194-201. PubMed ID: 22278423
[TBL] [Abstract][Full Text] [Related]
11. The incidence of endogenous Cushing's syndrome in the modern era.
Wengander S; Trimpou P; Papakokkinou E; Ragnarsson O
Clin Endocrinol (Oxf); 2019 Aug; 91(2):263-270. PubMed ID: 31094003
[TBL] [Abstract][Full Text] [Related]
12. Surgical outcomes and multidisciplinary management strategy of Cushing's disease: a single-center experience in China.
Zhang K; Shen M; Qiao N; Chen Z; He W; Ma Z; Shou X; Li S; Zhao Y; Pan L; Liu D; He M; Zhang Z; Li Y; Yao Z; Ye H; Wang Y
Neurosurg Focus; 2020 Jun; 48(6):E7. PubMed ID: 32480378
[TBL] [Abstract][Full Text] [Related]
13. Factors predicting long-term comorbidities in patients with Cushing's syndrome in remission.
Schernthaner-Reiter MH; Siess C; Gessl A; Scheuba C; Wolfsberger S; Riss P; Knosp E; Luger A; Vila G
Endocrine; 2019 Apr; 64(1):157-168. PubMed ID: 30467627
[TBL] [Abstract][Full Text] [Related]
14. Complications and mortality of Cushing's disease: report on data collected over a 20-year period at a referral centre.
Mondin A; Ceccato F; Voltan G; Mazzeo P; Manara R; Denaro L; Scaroni C; Barbot M
Pituitary; 2023 Oct; 26(5):551-560. PubMed ID: 37495935
[TBL] [Abstract][Full Text] [Related]
15. Negative surgical exploration in patients with Cushing's disease: benefit of two-thirds gland resection on remission rate and a review of the literature.
Carr SB; Kleinschmidt-DeMasters BK; Kerr JM; Kiseljak-Vassiliades K; Wierman ME; Lillehei KO
J Neurosurg; 2018 Nov; 129(5):1260-1267. PubMed ID: 29219752
[TBL] [Abstract][Full Text] [Related]
16. Results of gamma knife surgery for Cushing's disease.
Sheehan JP; Xu Z; Salvetti DJ; Schmitt PJ; Vance ML
J Neurosurg; 2013 Dec; 119(6):1486-92. PubMed ID: 23930850
[TBL] [Abstract][Full Text] [Related]
17. Low immediate postoperative serum-cortisol nadir predicts the short-term, but not long-term, remission after pituitary surgery for Cushing's disease.
Ramm-Pettersen J; Halvorsen H; Evang JA; Rønning P; Hol PK; Bollerslev J; Berg-Johnsen J; Helseth E
BMC Endocr Disord; 2015 Oct; 15():62. PubMed ID: 26499317
[TBL] [Abstract][Full Text] [Related]
18. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit.
Yap LB; Turner HE; Adams CB; Wass JA
Clin Endocrinol (Oxf); 2002 Jan; 56(1):25-31. PubMed ID: 11849243
[TBL] [Abstract][Full Text] [Related]
19. Cabergoline may act as a radioprotective agent in Cushing's disease.
Thakkar K; Lila A; Sarathi V; Ramteke-Jadhav S; Goroshi M; Memon SS; Krishnatry R; Gupta T; Jalali R; Goel A; Shah A; Sankhe S; Patil V; Bandgar T; Shah NS
Clin Endocrinol (Oxf); 2020 Jan; 92(1):55-62. PubMed ID: 31698511
[TBL] [Abstract][Full Text] [Related]
20. Management of Cushing's disease: a single-center experience.
Solak M; Kraljevic I; Dusek T; Melada A; Kavanagh MM; Peterkovic V; Ozretic D; Kastelan D
Endocrine; 2016 Mar; 51(3):517-23. PubMed ID: 26215278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
